Literature DB >> 15632009

Early events in the pathogenesis of eastern equine encephalitis virus in mice.

Peter Vogel1, Wayne M Kell, David L Fritz, Michael D Parker, Randal J Schoepp.   

Abstract

To elucidate the pathogenesis of eastern equine encephalitis (EEE) virus infections, we used histopathology, immunohistochemistry, and in situ hybridization to track the spread and early cellular targets of viral infection in mice. Young mice were inoculated with virulent EEE virus in their right rear footpad and were followed in a time-course study for 4 days. Virulent EEE virus produced a biphasic illness characterized by an early self-limiting replication phase in peripheral tissues followed by an invariably fatal central nervous system (CNS) phase. In the early extraneural phase, there was primary amplifying replication of virus within fibroblasts at the inoculation site and within osteoblasts in active growth areas of bone that resulted in a transient high-titer viremia. Pathological changes and viral infection were observed as early as 12 hours post-infection (PI) in osteoblasts, skeletal muscle myocytes, and in fibroblasts along fascial sheaths. The severity and extent of infection in peripheral tissues peaked at day 1 PI. In the neural phase of infection, virus was first detected in the brain on day 1 PI, with rapid interneuronal spread of infection leading to death by day 4 PI. EEE virus appeared to be directly cytopathic for neurons. The very rapid onset and apparently random and widely dispersed infection in the CNS, with concurrent sparing of olfactory neuroepithelium, strongly suggests that invasion of the CNS by EEE occurs by a vascular route, rather than via peripheral nerves or the olfactory neuroepithelium. Our finding that metaphyseal osteoblasts are an early site of amplifying viral replication may explain the higher-titer viremias and higher incidence of neuroinvasion and fulminant encephalitis seen in the young, and may also explain why mature animals become refractory to encephalitis after peripheral inoculation with EEE virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632009      PMCID: PMC1602312          DOI: 10.1016/S0002-9440(10)62241-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  Role of antibodies in controlling alphavirus infection of neurons.

Authors:  D E Griffin; S Ubol; P Desprès; T Kimura; A Byrnes
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus.

Authors:  D E Griffin
Journal:  J Infect Dis       Date:  1976-04       Impact factor: 5.226

3.  Surveillance of arboviral encephalitis in the United States, 1955-1971.

Authors:  J E McGowan; J A Bryan; M B Gregg
Journal:  Am J Epidemiol       Date:  1973-03       Impact factor: 4.897

4.  1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells.

Authors:  J M Schlaeppi; S Gutzwiller; G Finkenzeller; B Fournier
Journal:  Endocr Res       Date:  1997-08       Impact factor: 1.720

Review 5.  Molecular biology of matrix vesicles.

Authors:  H C Anderson
Journal:  Clin Orthop Relat Res       Date:  1995-05       Impact factor: 4.176

6.  Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.

Authors:  L J White; J G Wang; N L Davis; R E Johnston
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 7.  Age-dependent susceptibility to fatal encephalitis: alphavirus infection of neurons.

Authors:  D E Griffin; B Levine; W R Tyor; P C Tucker; J M Hardwick
Journal:  Arch Virol Suppl       Date:  1994

8.  Isolation of eastern equine encephalitis virus from Aedes albopictus in Florida.

Authors:  C J Mitchell; M L Niebylski; G C Smith; N Karabatsos; D Martin; J P Mutebi; G B Craig; M J Mahler
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

Review 9.  Medically important arboviruses of the United States and Canada.

Authors:  C H Calisher
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

10.  Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy.

Authors:  T P Monath; C B Cropp; A K Harrison
Journal:  Lab Invest       Date:  1983-04       Impact factor: 5.662

View more
  28 in total

1.  Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.

Authors:  Michael Zasloff; A Paige Adams; Bernard Beckerman; Ann Campbell; Ziying Han; Erik Luijten; Isaura Meza; Justin Julander; Abhijit Mishra; Wei Qu; John M Taylor; Scott C Weaver; Gerard C L Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

3.  Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice.

Authors:  Eryu Wang; Olga Petrakova; A Paige Adams; Patricia V Aguilar; Wenli Kang; Slobodan Paessler; Sara M Volk; Ilya Frolov; Scott C Weaver
Journal:  Vaccine       Date:  2007-08-15       Impact factor: 3.641

4.  Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Authors:  Aaron T Phillips; Amber B Rico; Charles B Stauft; Sean L Hammond; Tawfik A Aboellail; Ronald B Tjalkens; Ken E Olson
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.

Authors:  Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton
Journal:  Am J Trop Med Hyg       Date:  2014-05-19       Impact factor: 2.345

6.  Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Authors:  Janice M Rusnak; Lesley C Dupuy; Nancy A Niemuth; Andrew M Glenn; Lucy A Ward
Journal:  Comp Med       Date:  2018-10-03       Impact factor: 0.982

7.  Susceptibility of the Aotus nancymaae owl monkey to eastern equine encephalitis.

Authors:  Benjamin J Espinosa; Scott C Weaver; Slobodan Paessler; Douglas Brining; Milagros Salazar; Tadeusz Kochel
Journal:  Vaccine       Date:  2009-01-30       Impact factor: 3.641

8.  Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.

Authors:  Patricia V Aguilar; A Paige Adams; Eryu Wang; Wenli Kang; Anne-Sophie Carrara; Michael Anishchenko; Ilya Frolov; Scott C Weaver
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

9.  Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis.

Authors:  Christina L Gardner; Crystal W Burke; Mulu Z Tesfay; Pamela J Glass; William B Klimstra; Kate D Ryman
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

10.  Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs.

Authors:  Chad J Roy; Douglas S Reed; Catherine L Wilhelmsen; Justin Hartings; Sarah Norris; Keith E Steele
Journal:  Virol J       Date:  2009-10-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.